Proscia Builds Momentum In Life Sciences Market Led By Customer And Product Growth
admin@pathologynews.com2023-02-17T16:36:00+00:0014 of the top 20 pharmaceutical companies now rely on Concentriq to accelerate R&D
14 of the top 20 pharmaceutical companies now rely on Concentriq to accelerate R&D
Here at Proscia, it seems like we have a front row seat to the increasingly complex challenges facing R&D in the life sciences. For our customers, the processes, systems, and data models used in research are more sophisticated than ever. More stakeholders mean more requirements. More compliance policies mean more reporting. And when it comes to digital pathology, more images mean more surface area for messy data.
Multiplex tissue staining can generate large amounts of data to help identify distinct information about particular cells in tissue.
Precise classification of histopathological images is crucial to computer-aided diagnosis in clinical practice. Magnification-based learning networks have attracted considerable attention for their ability to improve performance in histopathological classification. However, the fusion of pyramids of histopathological images at different magnifications is an under-explored area. In this paper, we proposed a novel deep multi-magnification similarity learning (DSML) approach that can be useful for the interpretation of multi-magnification learning framework and easy to visualize feature representation from low-dimension (e.g., cell-level) to high-dimension (e.g., tissue-level), which has overcome the difficulty of understanding cross-magnification information propagation. It uses a similarity cross entropy loss function designation to simultaneously learn the similarity of the information among cross-magnifications. In order to verify the effectiveness of DMSL, experiments with different network backbones and different magnification combinations were designed, and its ability to interpret was also investigated through visualization. Our experiments were performed on two different histopathological datasets: a clinical nasopharyngeal carcinoma and a public breast cancer BCSS2021 dataset. The results show that our method achieved outstanding performance in classification with a higher value of area under curve, accuracy, and F-score than other comparable methods. Moreover, the reasons behind multi-magnification effectiveness were discussed.
by Christos Evangelou, MSc, PhD – Medical Writer and Editor The clinical utility of deep learning has been investigated extensively. Indeed, deep learning algorithms have shown promising diagnostic performance in digital pathology applications. However, site-dependent differences in preanalytical variables, such as the type of slide scanner and staining procedure, may lead to the generation of whole slide [...]
After experimenting with multidimensional, multimarker, and multicolor single-cell imaging modalities during his postdoc at Beth Israel Deaconess Medical Center in Boston, looking at 2D images of tissue stained just with hematoxylin and eosin (H&E) seemed to him a bit simplistic…and then he was tasked with doing tissue image analysis (IA). When relying just on H&E, IA can be a very challenging task. So, to both simplify it and extract more information from the tissue, multiplex staining can be implemented.
Aiforia has received a contract award to provide artificial intelligence solutions for 25 NHS Trusts pathology departments in the UK to support the diagnosis of patients.
Tribun Health named Best Digital Pathology Provider in Europe thanks to rigorous evaluation by its customers. PARIS, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Tribun Health, software developer and provider of CaloPix, the leading comprehensive AI-enabled diagnostic platform on the market, is proud to announce today that it has won the prestigious "Best in KLAS Digital Pathology" award [...]
Since launching Automated QC in May of 2022, our customers have achieved dramatic workflow efficiencies and quality benefits, and these companies are now charting a course for a computational future that accelerates discovery with artificial intelligence (AI).
Diagnexia's Chief Medical Officer, Prof. Runjan Chetty, spoke with Unity 101 radio station this week to discuss the role and importance of pathologists in the NHS, the reason for shortages in pathologists, and the role digital pathology and Diagnexia can play in overcoming some of the issues the NHS face with test backlogs and delayed diagnoses.
© Copyright 2025, Bioincyte Ltd
PathologyNews Chat
